Physician profile
Timothy Scott Smyth
NPI 1548212137
$1,133.69
in general payments reported to CMS, 2019-2025
14 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Addiction Medicine (Anesthesiology) provider received nationally (typical 2025 total: $133).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.11 · 2020: $120 · 2021: $170 · 2022: $223 · 2023: $240 · 2024: $105 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.38 | 2021-2025 | Vraylar, Mavyret |
| Gilead Sciences, INC. | $247.82 | 2021-2023 | Epclusa |
| Vanda Pharmaceuticals INC. | $167.52 | 2024-2025 | Fanapt, Hetlioz |
| Allergan, INC. | $92.43 | 2020 | |
| Axsome Therapeutics, INC. | $83.78 | 2023-2024 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $69.68 | 2021-2025 | Rexulti |
| Boston Scientific Corporation | $28.06 | 2020 | |
| Avanir Pharmaceuticals, INC. | $21.53 | 2019 | |
| Indivior INC. | $21.42 | 2024 | Sublocade |
| Alkermes, INC. | $19.40 | 2021 | |
| Sunovion Pharmaceuticals INC. | $18.23 | 2019 | |
| Lundbeck LLC | $14.80 | 2023 | Rexulti |
| Braeburn INC. | $14.29 | 2025 | Brixadi |
| Mdd US Operations, LLC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Smyth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.